A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study to Assess Haemodynamic Effects of Serelaxin in Patients With Acute Heart Failure

Study Questions:

Does serelaxin, a recombinant form of human relaxin-2, improve hemodynamics in patients admitted with acute heart failure (AHF)?